COULIE BERNARD (President and CEO) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/27/2025ACC: 0001746473-25-000009
DirectorOfficer· President and CEO
Since Jun 2020
+487.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
487.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+162.50K
Price / share
—
Trade value
—
% of position
37.7%
1/23/2025
430.52K→593.02K
Total
Net shares
+162.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | A · Award | +162.50K | — | — | 37.7% | 430.52K | 593.02K |
| Total | +162.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
325K shares
Shares
+325K
Strike price
11.14
Held after
325K
Exercisable
—
1/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock325K shares | 1/23/2025 | A · Award | +325K | 11.14 | — | 325K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned409.32K
Total
409.32K indirect409.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 409.32K | Indirect |
| Total | 409.32K | 409.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported